Keenova Therapeutics plc, a leading US-focused branded therapeutics company, announced positive results from its phase 3 clinical trial of Xiaflex (collagenase clostridium histolyticum) for the ...
Keenova Therapeutics is hoping to step into a new market with Xiaflex (collagenase clostridium histolyticum), after the drug netted a Phase III win in rare foot disease, plantar fibromatosis. To put ...
Treatment with CCH led to a clinically meaningful and statistically significant reduction in daily foot pain at week 12 compared with placebo. Topline data were announced from a phase 3 trial ...
Keenova Therapeutics plc announced today positive results from its Phase 3 clinical trial of XIAFLEX® (collagenase clostridium ...
Keenova Therapeutics plc announced today positive results from its Phase 3 clinical trial of XIAFLEX® (collagenase clostridium histolyticum) for the treatment of plantar fibromatosis, a chronic ...
Keenova Therapeutics achieved statistically significant primary and secondary endpoints in its Phase 3 trial of XIAFLEX. The pivotal study demonstrated meaningful foot pain reduction and functional ...
Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? Aging is a gift, but that doesn’t always mean we’re thrilled to see it ...
If you experience the fiery heel pain of plantar fasciitis, you need relief now. What works fastest? Experts share their picks for the most effective stretch, the best shoe, the fastest-acting splint, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results